Schistosome ABC multidrug transporters: From pharmacology to physiology.
Schistosome ABC multidrug transporters: From pharmacology to physiology.
复制标题
DOI:
10.1016/j.ijpddr.2014.09.007
复制
发表时间:
2014-12
影响因子:
4
通讯作者:
Greenberg, Robert M.
中科院分区:
文献类型:
--
作者:
Greenberg, Robert M.
关键词:
The genuine and hypothesized roles of schistosome ABC transporters are reviewed. Evidence suggesting a role for transporters in schistosome drug susceptibility is discussed. Potential roles of ABC transporters in normal schistosome biology are outlined. Praziquantel (PZQ) is essentially the only drug currently available for treatment and control of schistosomiasis, a disease affecting hundreds of millions worldwide. Though highly effective overall, PZQ has limitations, most notably its significant lack of activity against immature schistosomes. Furthermore, the availability of only a single drug for a disease of this magnitude makes reports of PZQ-resistant isolates particularly troubling. ATP-binding cassette (ABC) multidrug transporters such as P-glycoprotein (Pgp; ABCB1) are efflux transporters that underlie multidrug resistance (MDR); changes in their expression or structure are also associated with drug resistance in parasites, including helminths. This review will discuss the role these transporters might play in modulating schistosome susceptibility to PZQ, and the implications for developing new or repurposed treatments that enhance the efficacy of PZQ. However, in addition to influencing drug susceptibility, ABC transporters play important roles in several critical physiological functions such as excretion and maintenance of permeability barriers. They also transport signaling molecules with high affinity, and several lines of evidence implicate mammalian transporters in a diverse array of physiological functions, including regulation of immune responses. Like their mammalian counterparts, schistosome ABC transporters appear to be involved in functions critical to the parasite, including excretory activity and reproduction, and we hypothesize that they underlie at least some aspects of parasite–host interactions. Thus, in addition to their potential as targets for enhancers of PZQ susceptibility, these transporters might also serve as candidate targets for agents that disrupt the parasite life cycle and act as antischistosomals on their own.
登录
查看更多内容
DOI:
10.1007/978-1-60761-416-6_15
发表时间:
2010-01-01
期刊:
MULTI-DRUG RESISTANCE IN CANCER
影响因子:
--
作者:
Coley, Helen M.
通讯作者:
Coley, Helen M.
DOI:
10.1126/science.1168750
发表时间:
2009-03-27
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Aller SG;Yu J;Ward A;Weng Y;Chittaboina S;Zhuo R;Harrell PM;Trinh YT;Zhang Q;Urbatsch IL;Chang G
通讯作者:
Chang G
影响因子:
4.8
作者:
Aksoy, E;Zouain, CS;Trottein, F
通讯作者:
Trottein, F
影响因子:
4.2
作者:
Chai JY
通讯作者:
Chai JY
影响因子:
2
作者:
Cioli, D;Pica-Mattoccia, L
通讯作者:
Pica-Mattoccia, L